Back to search
FDAFDA · Food and drugs·Recall number D-1123-2022

Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50

Published June 1, 2022 · Recall initiated: January 15, 2021

Summary

FDA records drug Class III recall D-1123-2022, published June 1, 2022 and initiated January 15, 2021. Recalling firm: Calvin Scott & Company, Inc.; Status: Terminated; Reported quantity: 13 bottles; Lot: CSI Lot: CS-20274-005, Exp 5/22. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Calvin Scott & Company, Inc.
Distributor
1 physician in Alpharetta, GA
Lot
CSI Lot: CS-20274-005, Exp 5/22
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50 recalled?

Yes. FDA published recall D-1123-2022 on June 1, 2022. Reported hazard: Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone